Save your place

Sign in to WhoBought

Please try again later.

Armata Pharmaceuticals, Inc. (ARMP) institutional ownership

Latest close $5.24 Jul 22, 2026
Market cap$90M 52-week range SectorHealthcare
Funds holding · Q1 2026
28
reported ARMP position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
21 buyers · 7 sellers

Armata Pharmaceuticals, Inc. (ARMP) price and institutional activity

Dates

Q1 2026

$0 bought by 21 investors
Madison Asset Management, LLCMillennium Management LLC +19 more
$0 sold by 7 investors
Renaissance Technologies LLCOmers Administration Corp +5 more
Bought Sold Totals per quarter; hover a bar for the names.

Armata Pharmaceuticals, Inc. (ARMP) institutional activity · 28

Investor Type Est. change Change Δ Own Date
Madison Asset Management, LLC · New
Change +2.1M Date Q1 2026
Madison Asset Management, LLC New· Q1 2026 +2.1M Q1 2026
Millennium Management LLC · Added
Change +232K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +232K Q1 2026
Dauntless Investment Group, LLC · Added
Change +84K Date Q1 2026
Dauntless Investment Group, LLC Added· Q1 2026 +84K Q1 2026
Vanguard · Added
Change +80K Date Q1 2026
Vanguard Added· Q1 2026 +80K Q1 2026
Informed Momentum Co LLC · New
Change +61K Date Q1 2026
Informed Momentum Co LLC New· Q1 2026 +61K Q1 2026
Susquehanna International Group, LLP · Added
Change +40K Date Q1 2026
Susquehanna International Group, LLP Added· Q1 2026 +40K Q1 2026
Renaissance Technologies LLC Reduced· Q1 2026 −30K −43.8% Q1 2026
Omers Administration Corp · Exited
Change −28K Δ Own −100.0% Date Q1 2026
Omers Administration Corp Exited· Q1 2026 −28K −100.0% Q1 2026
Hudson Bay Capital Management LP · New
Change +18K Date Q1 2026
Hudson Bay Capital Management LP New· Q1 2026 +18K Q1 2026
Goldman Sachs Group Inc · Added
Change +16K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +16K Q1 2026
Jane Street Group, LLC · Added
Change +11K Date Q1 2026
Jane Street Group, LLC Added· Q1 2026 +11K Q1 2026
Citadel Advisors LLC Exited· Q1 2026 −11K −100.0% Q1 2026
Hrt Financial LP · New
Change +11K Date Q1 2026
Hrt Financial LP New· Q1 2026 +11K Q1 2026
Bank of America Corp · Added
Change +8K Date Q1 2026
Bank of America Corp Added· Q1 2026 +8K Q1 2026
BlackRock · Reduced
Change −8K Date Q1 2026
BlackRock Reduced· Q1 2026 −8K Q1 2026
Data through Q1 2026 · filed May 15, 2026
15 of 28

Famous investor activity in Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals, Inc. (ARMP) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Birx Deborah · Director Tax withholding or exercise payment (F) -$60K
Price $4.26 Qty -14K Owned 198K ΔOwn −6.6% Trade date Jul 10, 2026 Filed date Jul 14, 2026
Birx Deborah Director Tax withholding or exercise payment (F) $4.26 -14K -$60K 198K −6.6% Jul 10, 2026 Jul 14, 2026
Gilmer Daniel B. · Director Grant (A) 51K
Owned 51K Trade date Apr 24, 2026 Filed date Apr 28, 2026
Gilmer Daniel B. Director Grant (A) 51K 51K Apr 24, 2026 Apr 28, 2026
Kyme Pierre · Officer Tax withholding or exercise payment (F) -$11K
Price $10.54 Qty -1K Owned 9K Trade date Mar 14, 2026 Filed date Mar 17, 2026
Kyme Pierre Officer Tax withholding or exercise payment (F) $10.54 -1K -$11K 9K Mar 14, 2026 Mar 17, 2026
Birx Deborah · Director, Officer Tax withholding or exercise payment (F) -$52K
Price $10.54 Qty -5K Owned 212K Trade date Mar 14, 2026 Filed date Mar 17, 2026
Birx Deborah Director, Officer Tax withholding or exercise payment (F) $10.54 -5K -$52K 212K Mar 14, 2026 Mar 17, 2026
Kramer Robin · Director Grant (A) 26K
Owned 26K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Kramer Robin Director Grant (A) 26K 26K Mar 9, 2026 Mar 11, 2026
Kyme Pierre · Officer Grant (A) 183K
Owned 183K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Kyme Pierre Officer Grant (A) 183K 183K Mar 9, 2026 Mar 11, 2026
House David Duane · Officer Grant (A) 110K
Owned 110K Trade date Mar 9, 2026 Filed date Mar 11, 2026
House David Duane Officer Grant (A) 110K 110K Mar 9, 2026 Mar 11, 2026
Patti Joseph M. · Director Grant (A) 26K
Owned 26K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Patti Joseph M. Director Grant (A) 26K 26K Mar 9, 2026 Mar 11, 2026
Peterson Todd C. · Director Grant (A) 26K
Owned 26K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Peterson Todd C. Director Grant (A) 26K 26K Mar 9, 2026 Mar 11, 2026
Odysseas Kostas D. · Director Grant (A) 26K
Owned 26K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Odysseas Kostas D. Director Grant (A) 26K 26K Mar 9, 2026 Mar 11, 2026
Birx Deborah · Director Grant (A) 421K
Owned 421K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Birx Deborah Director Grant (A) 421K 421K Mar 9, 2026 Mar 11, 2026
Schlesinger Sarah J. · Director Grant (A) 26K
Owned 26K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Schlesinger Sarah J. Director Grant (A) 26K 26K Mar 9, 2026 Mar 11, 2026
Haimovitz Jules · Director Grant (A) 26K
Owned 26K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Haimovitz Jules Director Grant (A) 26K 26K Mar 9, 2026 Mar 11, 2026
13 of 13

Armata Pharmaceuticals, Inc. (ARMP) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Innoviva, Inc. 64.2M
% of shares outstanding 85.2% Filing date Nov 14, 2024
Innoviva, Inc. 64.2M 85.2% Nov 14, 2024
Innoviva, Inc. 55.5M
% of shares outstanding 82.7% Filing date May 13, 2026
Innoviva, Inc. 55.5M 82.7% May 13, 2026
2 of 2

Armata Pharmaceuticals, Inc. (ARMP) ownership FAQ

Who owns ARMP?

28 reporting institutions disclosed ARMP position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.